Dizon, Glenda D.
HRN: 10-65-80 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/23/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/23/2026
07/30/2026
IV
4.5g
Q8H
INFECTED WOUND, BIG TOE, RIGH
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: